Strata Critical Medical, Inc. (SRTA) Profit Margins
Over the twelve months to 2026-06-30, Strata Critical Medical, Inc. (SRTA) had gross margin 21.3%, operating margin -8.0%, net margin 15.7%, free cash flow margin -19.3%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SRTAStrata Critical Medical, Inc.Follow SRTA — free
—
Price chart with a free account
- Market cap
- 412.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2021 Sep 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | 20.8% | 15.2% | 18.7% | 20.2% | 20.9% | 21.3% | |
| Operating margin | -47.7% | -36.6% | -30.3% | -15.3% | -11.3% | -8.0% | |
| Net margin | -79.3% | -18.7% | -24.9% | -18.6% | 21.0% | 15.7% | |
| FCF margin | -31.5% | -25.9% | -15.3% | -24.2% | -30.4% | -19.3% |
USD millions · SEC XBRL
Strata Critical Medical, Inc. — questions
- What is Strata Critical Medical, Inc.'s gross margin?
- 21.3% over the twelve months to 2026-06-30.
- What is Strata Critical Medical, Inc.'s operating margin?
- -8.0% over the twelve months to 2026-06-30.
- What is Strata Critical Medical, Inc.'s net profit margin?
- 15.7% over the twelve months to 2026-06-30.
Every figure on this page comes from Strata Critical Medical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.